Can-Fite BioPharma American Depositary Shares
CANF
9 hedge funds and large institutions have $844K invested in Can-Fite BioPharma American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
222% more capital invested
Capital invested by funds: $262K → $844K (+$581K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
18% less funds holding
Funds holding: 11 → 9 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.19M |
| 2 |
Morgan Stanley
New York
|
+$10.6K |
| 3 |
JP Morgan Chase
New York
|
+$359 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$16.5K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$7.36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$575 |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$245 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $756K | +$1.19M | +16,500 | New |
|
|
2
Morgan Stanley
New York
| $76.5K | +$10.6K | +147 | +10% |
|
3
Fifth Third Bancorp
Cincinnati,
Ohio
| $6.87K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1.64K | -$575 | -8 | -18% |
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $1.35K | – | – | – |
|
6
Citigroup
New York
| $1.27K | – | – | – |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $121 | – | – | – |
|
|
TWC
8
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $59 | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20.1K | -164 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$16.5K | -135 | Closed |
|
|
11
Stifel Financial
St. Louis,
Missouri
| – | -$7.36K | -60 | Closed |
|
|
12
BNP Paribas Financial Markets
Paris,
France
| – | -$245 | -2 | Closed |
|
|
13
JP Morgan Chase
New York
| – | +$359 | +5 | New |
|
CANF Hedge Fund Activity: Q1 2023 in Review
9 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2023, worth a combined $844K — up 222% from $262K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.19M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $20.1K sold.
- 9 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2023, down from 11 in Q4 2022.
- Funds reported $844K of Can-Fite BioPharma American Depositary Shares stock for Q1 2023, up 222% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2023 and 4 closed out, a net change of -2 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2023 was Armistice Capital, an estimated $1.19M added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2023 was Susquehanna International Group, an estimated $20.1K sold.
Based on aggregated 13F filings for Q1 2023.